KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Debt Ratio (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Debt Ratio for 18 consecutive years, with 0.13 as the latest value for Q1 2026.

  • For Q1 2026, Debt Ratio changed N/A year-over-year to 0.13; the TTM value through Mar 2026 reached 0.13, changed N/A, while the annual FY2025 figure was 0.13, 655.25% up from the prior year.
  • Debt Ratio hit 0.13 in Q1 2026 for Ionis Pharmaceuticals, down from 0.13 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.21 in Q2 2025 and bottomed at 0.0 in Q1 2023.
  • Average Debt Ratio over 5 years is 0.06, with a median of 0.02 recorded in 2024.
  • Year-over-year, Debt Ratio plummeted 87.92% in 2023 and then skyrocketed 1341.29% in 2025.
  • Ionis Pharmaceuticals' Debt Ratio stood at 0.01 in 2022, then soared by 357.15% to 0.03 in 2023, then crashed by 40.01% to 0.02 in 2024, then surged by 655.25% to 0.13 in 2025, then dropped by 3.98% to 0.13 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.13, 0.13, and 0.21 for Q1 2026, Q4 2025, and Q3 2025 respectively.